Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease-Reference-Cited by-同舟云学术

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease

Published:2019-06-22 Issue:1 Volume:21 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Miyagawa Ippei,Nakano Kazuhisa,Iwata Shigeru,Nakayamada Shingo,Saito Kazuyoshi,Hanami Kentaro,Fukuyo Shunsuke,Kubo Satoshi,Kawabe Akio,Miyazaki Yusuke,Tanaka Yoshiya^ORCID

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-019-1933-8.pdf

Reference18 articles.

1. O’Duffy JD. Behcet’s disease. Curr Opin Rheumatol. 1994;6:39–43.

2. Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Hanami K, et al. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero- Behcet’s disease. Mod Rheumatol. 2011;21:184–91.

3. Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, et al. Effects of anti-TNF-alpha antibody infliximab in refractory entero- Behcet’s disease. Rheumatology. 2009;49:1012–3.

4. Inoue N, Kobayashi K, Naganuma M, Hirai F, Ozawa M, Arikan D, et al. Long-term safety and efficacy of adalimumab for intestinal Behçet’s disease in the open label study following a phase 3 clinical trial. Intest Res. 2017;15:395–401.

5. Hibi T, Hirohata S, Kikuchi H, Tateishi U, Sato N, Ozaki K, et al. Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Medicine (Baltimore). 2016;95:e3863.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical manifestations and treatment outcomes of Behçet's disease: A single‐center experience;Health Science Reports;2024-07

2. Adamantiades–Behçet Disease;Rook's Textbook of Dermatology;2024-03-19

3. Rapid Progression of Large B-cell Lymphoma in Behçet's Disease on Immunosuppressive Therapy: A Case Report with Literature Review;Cureus;2022-08-15

4. Entero-Behcet: A Challenging Aspect of Behcet Disease;Rare Diseases - Recent Advances [Working Title];2022-05-31

5. Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome;Therapeutic Advances in Musculoskeletal Disease;2022-01